The Fermenters and Bioreactors Market Size is valued at USD 21.5 Bn in 2023 and is predicted to reach USD 43.2 Bn by the year 2031 at an 9.2% CAGR during the forecast period for 2024-2031.
Fermenters and bioreactors are crucial tools across various industries, including pharmaceuticals, food and beverage, and chemical production. They create optimal environments for the growth and cultivation of microorganisms, cells, and tissues, facilitating the production of a wide range of products such as antibodies, vaccines, enzymes, and biofuels. While fermenters are primarily used for bacterial and fungal cell growth in controlled conditions, bioreactors serve larger-scale applications, particularly in the biopharmaceutical sector for producing vaccines, monoclonal antibodies, and other biologics. These systems enable precise control of essential parameters like temperature, pH, dissolved oxygen, and nutrient levels, ensuring ideal growth conditions for the target organisms or cells.
The growing demand for personalized medicine, biologics, and treatments for orphan diseases significantly drives the fermenters and bioreactors market. Increasing health concerns stemming from unhealthy lifestyles have heightened the need for specialized therapies, propelling demand in the biopharmaceutical industry. As these innovative treatments become more critical, the reliance on bioreactors and fermenters is expected to expand, underscoring their vital role in advancing healthcare solutions.
The fermenters and bioreactors market type of product, fabrication material, type of bioprocess, type of biologic. By type of product the market is segmented into bioreactors and fermenters, by fabrication material market is segmented into glass, stainless steel, single use. By type of bioprocess market is segmented into batch and fed-batch, continuous. By type of biologic the market is segmented into antibodies, vaccines, cell therapies, other biologics.
The continuous bioprocess segment is significantly driving growth in the fermenters and bioreactors market due to its numerous advantages over traditional batch and fed-batch processes. Continuous bioprocessing allows for uninterrupted production, resulting in higher yields and reduced costs, as it eliminates downtime between cycles. This method facilitates real-time monitoring and control, enhancing product quality and consistency by maintaining steady-state conditions for critical parameters like pH, temperature, and nutrient levels. Additionally, continuous manufacturing reduces capital and operating expenses through increased productivity, lower water and energy consumption, and expedited processing times, while also minimizing the need for intermediate holding tanks and repeated sterilization steps.
The biopharmaceutical industry is experiencing rapid growth in antibody-based therapeutics, with innovative formats such as bi-specific antibodies, antibody-drug conjugates, and Fc fusion proteins gaining significant traction. Antibodies are versatile and effective in targeting a wide range of diseases, including cancer, autoimmune disorders, and infectious diseases, due to their specificity and ability to bind precisely to targets. This surge in approved and pipeline antibody therapeutics has created a high demand for bioreactor technologies necessary for their commercial-scale manufacturing. As a result, biopharmaceutical companies are making substantial investments in next-generation antibody engineering and production capabilities to meet this growing need.
North America is witnessing significant growth in the fermenters and bioreactors market, driven by technological advancements, particularly in single-use disposable bioreactors, which have facilitated widespread adoption in the region. The strong presence of established biopharmaceutical companies and bioprocessing equipment manufacturers, such as Thermo Fisher Scientific, GE Healthcare, and Danaher Corporation, has further fueled demand for these technologies. Additionally, increasing investments in biotechnology research and development are propelling growth, as companies strive to create next-generation products with advanced features. The rising demand for biopharmaceuticals, including vaccines, monoclonal antibodies, and other biologics, is also driving the need for bioreactors and fermenters to support their manufacturing processes.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 21.5 Bn |
|
Revenue Forecast In 2031 |
USD 43.2 Bn |
|
Growth Rate CAGR |
CAGR of 9.2% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Type of Product, Fabrication Material, Type of Bioprocess, Type of Biologic and By Region |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
|
Competitive Landscape |
Getinge (Applikon), Bionet, Cytiva, Eppendorf, Merck, Ollital Technology, Parr Instrument Company, Sartorius, Shanghai Bailun Biological Technology Solaris Biotech (Donaldson), Solida Biotech, Zhengzhou Laboao Instrument Equipment (LABAO) |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Fermenters and Bioreactors Market Snapshot
Chapter 4. Global Fermenters and Bioreactors Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type of Product Estimates & Trend Analysis
5.1. by Type of Product & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type of Product:
5.2.1. Bioreactors
5.2.2. Fermenters
Chapter 6. Market Segmentation 2: by Fabrication Material Estimates & Trend Analysis
6.1. by Fabrication Material & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Fabrication Material:
6.2.1. Glass
6.2.2. Stainless Steel
6.2.3. Single Use
Chapter 7. Market Segmentation 3: by Type of Bioprocess Estimates & Trend Analysis
7.1. by Type of Bioprocess & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type of Bioprocess:
7.2.1. Batch and Fed-batch
7.2.2. Continuous
Chapter 8. Market Segmentation 4: by Type of Biologic Estimates & Trend Analysis
8.1. by Type of Biologic & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type of Biologic:
8.2.1. Antibodies
8.2.2. Vaccines
8.2.3. Cell Therapies
8.2.4. Other Biologics
Chapter 9. Fermenters and Bioreactors Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Fermenters and Bioreactors Market Revenue (US$ Million) Estimates and Forecasts by Type of Product, 2024-2031
9.1.2. North America Fermenters and Bioreactors Market Revenue (US$ Million) Estimates and Forecasts by Fabrication Material, 2024-2031
9.1.3. North America Fermenters and Bioreactors Market Revenue (US$ Million) Estimates and Forecasts by Type of Bioprocess, 2024-2031
9.1.4. North America Fermenters and Bioreactors Market Revenue (US$ Million) Estimates and Forecasts by Type of Biologic, 2024-2031
9.1.5. North America Fermenters and Bioreactors Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.2. Europe
9.2.1. Europe Fermenters and Bioreactors Market Revenue (US$ Million) Estimates and Forecasts by Type of Product, 2024-2031
9.2.2. Europe Fermenters and Bioreactors Market Revenue (US$ Million) Estimates and Forecasts by Fabrication Material, 2024-2031
9.2.3. Europe Fermenters and Bioreactors Market Revenue (US$ Million) Estimates and Forecasts by Type of Bioprocess, 2024-2031
9.2.4. Europe Fermenters and Bioreactors Market Revenue (US$ Million) Estimates and Forecasts by Type of Biologic, 2024-2031
9.2.5. Europe Fermenters and Bioreactors Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.3. Asia Pacific
9.3.1. Asia Pacific Fermenters and Bioreactors Market Revenue (US$ Million) Estimates and Forecasts by Type of Product, 2024-2031
9.3.2. Asia Pacific Fermenters and Bioreactors Market Revenue (US$ Million) Estimates and Forecasts by Fabrication Material, 2024-2031
9.3.3. Asia-Pacific Fermenters and Bioreactors Market Revenue (US$ Million) Estimates and Forecasts by Type of Bioprocess, 2024-2031
9.3.4. Asia-Pacific Fermenters and Bioreactors Market Revenue (US$ Million) Estimates and Forecasts by Type of Biologic, 2024-2031
9.3.5. Asia Pacific Fermenters and Bioreactors Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.4. Latin America
9.4.1. Latin America Fermenters and Bioreactors Market Revenue (US$ Million) Estimates and Forecasts by Type of Product, 2024-2031
9.4.2. Latin America Fermenters and Bioreactors Market Revenue (US$ Million) Estimates and Forecasts by Fabrication Material, 2024-2031
9.4.3. Latin America Fermenters and Bioreactors Market Revenue (US$ Million) Estimates and Forecasts by Type of Bioprocess, 2024-2031
9.4.4. Latin America Fermenters and Bioreactors Market Revenue (US$ Million) Estimates and Forecasts by Type of Biologic, 2024-2031
9.4.5. Latin America Fermenters and Bioreactors Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.5. Middle East & Africa
9.5.1. Middle East & Africa Fermenters and Bioreactors Market Revenue (US$ Million) Estimates and Forecasts by Type of Product, 2024-2031
9.5.2. Middle East & Africa Fermenters and Bioreactors Market Revenue (US$ Million) Estimates and Forecasts by Fabrication Material, 2024-2031
9.5.3. Middle East & Africa Fermenters and Bioreactors Market Revenue (US$ Million) Estimates and Forecasts by Type of Bioprocess, 2024-2031
9.5.4. Middle East & Africa Fermenters and Bioreactors Market Revenue (US$ Million) Estimates and Forecasts by Type of Biologic, 2024-2031
9.5.5. Middle East & Africa Fermenters and Bioreactors Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Getinge (Applikon)
10.2.2. Bionet
10.2.3. Cytiva
10.2.4. Eppendorf
10.2.5. Merck
10.2.6. Ollital Technology
10.2.7. Parr Instrument Company
10.2.8. Sartorius
10.2.9. Shanghai Bailun Biological Technology
10.2.10. Solaris Biotech
10.2.11. Solida Biotech
10.2.12. Zhengzhou Laboao Instrument Equipment (LABAO)
10.2.13. Other Prominent Players
Fermenters and Bioreactors Market by Type of Product -
Fermenters and Bioreactors Market by Fabrication Material -
Fermenters and Bioreactors Market by Type of Bioprocess -
Fermenters and Bioreactors Market by Type of Biologic -
Fermenters and Bioreactors Market by Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
